Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides

Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides

US Patent 8834866 · Granted Sep 16, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for treatment of Lafora disease2020
Methods and compositions for treatment of glycogen storage diseases and glycogen2020
Internalizing moieties2020
Internalizing moieties for treatment of cancer2019
Antisense conjugates for decreasing expression of DMPK2019
Internalizing moieties2019
Methods and compositions for treatment of glycogen storage diseases and glycogen2019
Methods and compositions for treatment of Pompe disease2018
Antisense conjugates for decreasing expression of DMPK2017
Methods and compositions for treatment of myotubular myopathy using chimeric pol2016
Methods and compositions for treatment of myotonic dystrophy2015
Methods and compositions for treatment of myotonic dystrophy2013